Richard Stephens, Patient Advocate, Chair of CRAF-UK, shared on LinkedIn:
“Excellent day on Friday at BHF alongside researchers, clinicians, funders, patients and caregivers to look at a research funding collaboration between BHF and Blood Cancer UK.
Very proud that the ESC cardio-oncology guidelines were cited often, and very pleased that we patients (and caregivers) made up 20% of the attendees.
Lots of good ideas, bags of willingness and bucketloads of enthusiasm – now we need to focus on delivering some tangible outcomes.
Watch this space.
Meanwhile – 2022 ESC Guidelines on cardio-oncology․”
You can also read:
Gilberto Lopes: Cardiovascular Risks Among Young Cancer Survivors.
Dipender Gill Raises Questions About Cardiovascular Risk and IL-6 Inhibition in ZEUS.